Title : A multicentre, open-label, observational local study to evaluate the low-density lipoprotein cholesterol-lowering effect of ezetimibe as prescribed in daily routine practice in the South African population.

Pub. Date : 2007 Sep-Oct

PMID : 17985033






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A multicentre, open-label, observational local study to evaluate the low-density lipoprotein cholesterol-lowering effect of ezetimibe as prescribed in daily routine practice in the South African population. Ezetimibe component of oligomeric golgi complex 2 Homo sapiens
2 RESULTS: In 358 patients, ezetimibe co-administered with ongoing statin therapy significantly reduced the low-density lipoprotein cholesterol (LDL-C) level by an additional 21.9% in the total population. Ezetimibe component of oligomeric golgi complex 2 Homo sapiens
3 RESULTS: In 358 patients, ezetimibe co-administered with ongoing statin therapy significantly reduced the low-density lipoprotein cholesterol (LDL-C) level by an additional 21.9% in the total population. Ezetimibe component of oligomeric golgi complex 2 Homo sapiens
4 Ezetimibe co-administered with ongoing statin therapy also increased the number of patients reaching their LDL-C goals according to their risk category (2.5 mmol/l for category 1 patients and 3.0 mmol/l for category 2 patients). Ezetimibe component of oligomeric golgi complex 2 Homo sapiens